Cargando…
P777: EFFICACY AND SAFETY OF ROMIPLOSTIM COMBINED WITH CYCLOSPORINE A AS A FIRST-LINE TREATMENT IN PATIENTS WITH APLASTIC ANEMIA: A PHASE 2/3 CLINICAL TRIAL.
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430427/ http://dx.doi.org/10.1097/01.HS9.0000970012.99987.60 |
| _version_ | 1785090961315987456 |
|---|---|
| author | Chiba, Shigeru Wook Lee, Jong Ho Jang, Jun Yoon, Sung-Soo Oshikawa, Gaku Usuki, Kensuke Mun, Yeung-Chul Kawakita, Toshiro Imada, Kazunori Cheong, June-Won Noshiro, Masayoshi Matsuda, Akira Ozawa, Keiya Mitani, Kinuko Kanda, Yoshinobu Nakao, Shinji |
| author_facet | Chiba, Shigeru Wook Lee, Jong Ho Jang, Jun Yoon, Sung-Soo Oshikawa, Gaku Usuki, Kensuke Mun, Yeung-Chul Kawakita, Toshiro Imada, Kazunori Cheong, June-Won Noshiro, Masayoshi Matsuda, Akira Ozawa, Keiya Mitani, Kinuko Kanda, Yoshinobu Nakao, Shinji |
| author_sort | Chiba, Shigeru |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430427 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104304272023-08-17 P777: EFFICACY AND SAFETY OF ROMIPLOSTIM COMBINED WITH CYCLOSPORINE A AS A FIRST-LINE TREATMENT IN PATIENTS WITH APLASTIC ANEMIA: A PHASE 2/3 CLINICAL TRIAL. Chiba, Shigeru Wook Lee, Jong Ho Jang, Jun Yoon, Sung-Soo Oshikawa, Gaku Usuki, Kensuke Mun, Yeung-Chul Kawakita, Toshiro Imada, Kazunori Cheong, June-Won Noshiro, Masayoshi Matsuda, Akira Ozawa, Keiya Mitani, Kinuko Kanda, Yoshinobu Nakao, Shinji Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430427/ http://dx.doi.org/10.1097/01.HS9.0000970012.99987.60 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Chiba, Shigeru Wook Lee, Jong Ho Jang, Jun Yoon, Sung-Soo Oshikawa, Gaku Usuki, Kensuke Mun, Yeung-Chul Kawakita, Toshiro Imada, Kazunori Cheong, June-Won Noshiro, Masayoshi Matsuda, Akira Ozawa, Keiya Mitani, Kinuko Kanda, Yoshinobu Nakao, Shinji P777: EFFICACY AND SAFETY OF ROMIPLOSTIM COMBINED WITH CYCLOSPORINE A AS A FIRST-LINE TREATMENT IN PATIENTS WITH APLASTIC ANEMIA: A PHASE 2/3 CLINICAL TRIAL. |
| title | P777: EFFICACY AND SAFETY OF ROMIPLOSTIM COMBINED WITH CYCLOSPORINE A AS A FIRST-LINE TREATMENT IN PATIENTS WITH APLASTIC ANEMIA: A PHASE 2/3 CLINICAL TRIAL. |
| title_full | P777: EFFICACY AND SAFETY OF ROMIPLOSTIM COMBINED WITH CYCLOSPORINE A AS A FIRST-LINE TREATMENT IN PATIENTS WITH APLASTIC ANEMIA: A PHASE 2/3 CLINICAL TRIAL. |
| title_fullStr | P777: EFFICACY AND SAFETY OF ROMIPLOSTIM COMBINED WITH CYCLOSPORINE A AS A FIRST-LINE TREATMENT IN PATIENTS WITH APLASTIC ANEMIA: A PHASE 2/3 CLINICAL TRIAL. |
| title_full_unstemmed | P777: EFFICACY AND SAFETY OF ROMIPLOSTIM COMBINED WITH CYCLOSPORINE A AS A FIRST-LINE TREATMENT IN PATIENTS WITH APLASTIC ANEMIA: A PHASE 2/3 CLINICAL TRIAL. |
| title_short | P777: EFFICACY AND SAFETY OF ROMIPLOSTIM COMBINED WITH CYCLOSPORINE A AS A FIRST-LINE TREATMENT IN PATIENTS WITH APLASTIC ANEMIA: A PHASE 2/3 CLINICAL TRIAL. |
| title_sort | p777: efficacy and safety of romiplostim combined with cyclosporine a as a first-line treatment in patients with aplastic anemia: a phase 2/3 clinical trial. |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430427/ http://dx.doi.org/10.1097/01.HS9.0000970012.99987.60 |
| work_keys_str_mv | AT chibashigeru p777efficacyandsafetyofromiplostimcombinedwithcyclosporineaasafirstlinetreatmentinpatientswithaplasticanemiaaphase23clinicaltrial AT wookleejong p777efficacyandsafetyofromiplostimcombinedwithcyclosporineaasafirstlinetreatmentinpatientswithaplasticanemiaaphase23clinicaltrial AT hojangjun p777efficacyandsafetyofromiplostimcombinedwithcyclosporineaasafirstlinetreatmentinpatientswithaplasticanemiaaphase23clinicaltrial AT yoonsungsoo p777efficacyandsafetyofromiplostimcombinedwithcyclosporineaasafirstlinetreatmentinpatientswithaplasticanemiaaphase23clinicaltrial AT oshikawagaku p777efficacyandsafetyofromiplostimcombinedwithcyclosporineaasafirstlinetreatmentinpatientswithaplasticanemiaaphase23clinicaltrial AT usukikensuke p777efficacyandsafetyofromiplostimcombinedwithcyclosporineaasafirstlinetreatmentinpatientswithaplasticanemiaaphase23clinicaltrial AT munyeungchul p777efficacyandsafetyofromiplostimcombinedwithcyclosporineaasafirstlinetreatmentinpatientswithaplasticanemiaaphase23clinicaltrial AT kawakitatoshiro p777efficacyandsafetyofromiplostimcombinedwithcyclosporineaasafirstlinetreatmentinpatientswithaplasticanemiaaphase23clinicaltrial AT imadakazunori p777efficacyandsafetyofromiplostimcombinedwithcyclosporineaasafirstlinetreatmentinpatientswithaplasticanemiaaphase23clinicaltrial AT cheongjunewon p777efficacyandsafetyofromiplostimcombinedwithcyclosporineaasafirstlinetreatmentinpatientswithaplasticanemiaaphase23clinicaltrial AT noshiromasayoshi p777efficacyandsafetyofromiplostimcombinedwithcyclosporineaasafirstlinetreatmentinpatientswithaplasticanemiaaphase23clinicaltrial AT matsudaakira p777efficacyandsafetyofromiplostimcombinedwithcyclosporineaasafirstlinetreatmentinpatientswithaplasticanemiaaphase23clinicaltrial AT ozawakeiya p777efficacyandsafetyofromiplostimcombinedwithcyclosporineaasafirstlinetreatmentinpatientswithaplasticanemiaaphase23clinicaltrial AT mitanikinuko p777efficacyandsafetyofromiplostimcombinedwithcyclosporineaasafirstlinetreatmentinpatientswithaplasticanemiaaphase23clinicaltrial AT kandayoshinobu p777efficacyandsafetyofromiplostimcombinedwithcyclosporineaasafirstlinetreatmentinpatientswithaplasticanemiaaphase23clinicaltrial AT nakaoshinji p777efficacyandsafetyofromiplostimcombinedwithcyclosporineaasafirstlinetreatmentinpatientswithaplasticanemiaaphase23clinicaltrial |